About Willmark
Willmark is a company based in India. The company has 15 employees. Willmark offers products and services including Tablets and Capsules and Veterinary Products.
- Headquarter India
- Employees 15
- SectorsHealthcareAgriculture
- Email••••••••
- Social Facebook Instagram
- Legal Name Willmark Pharmaceuticals Private Limited
- Date of Incorporation 14 Mar, 1985
- Jurisdiction Punjab, India
- Annual Revenue₹9.49 Cr
FY 2025 · -7% YoY
- Net Loss-₹28.6 Lakh
FY 2025 · -3% margin
- EBITDA₹24.2 Lakh
FY 2025 · 3% margin
- Employee Count15
Associated legal entities of Willmark
Willmark operates through Willmark Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Willmark Pharmaceuticals Private Limited CIN U24232PB1985PTC006176 | Active | 14 Mar 1985 | – | ₹9.5 Cr | 15 | 2 | View details |
Products & Services of Willmark
Willmark offers a comprehensive portfolio of products and services, including Tablets and Capsules and Veterinary Products.
Tablets and capsules are produced for human healthcare applications across various dosage forms
Veterinary products, including animal feed supplements, are supplied for livestock health maintenance
Board of directors of Willmark Pharmaceuticals Private Limited (Willmark)
Willmark Pharmaceuticals Private Limited is the primary company behind Willmark. The board of Willmark Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Rajiv Bhardwaj, appointed in 1985.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajiv Bhardwaj DIN 01112300 | Managing Director | 14 Mar 1985 | 41 yrs 6 mo | Willmark Pharmaceuticals Private Limited |
| Rajan Bhardwaj DIN 00979554 | Director | 01 Apr 1998 | 28 yrs 6 mo | Willmark Pharmaceuticals Private Limited |
Financials of Willmark
Figures of Willmark Pharmaceuticals Private Limited, the primary company behind Willmark, for FY 2025. Revenue was ₹9.49 Cr (-7% year on year). Net loss was -₹28.6 Lakh (-3% margin). EBITDA was ₹24.2 Lakh (3% margin). Revenue has grown at a compounded annual rate of -5% over three years and 0% over five years.
- ₹9.49 CrRevenue · FY 2025 · -7% YoY
- -₹28.6 LakhNet loss · -3% margin
- ₹24.2 LakhEBITDA · 3% margin
- ₹2 LakhPaid-up capital
- 15Employees (provident fund records)
- -5%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Willmark Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Willmark
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Willmark
10 companies that operate in the same segment as Willmark (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Willmark
Willmark is headquartered in India.
Willmark has 15 employees.
The primary company behind Willmark, Willmark Pharmaceuticals Private Limited, reported revenue of ₹9.49 Cr for FY 2025, down 7% year on year.
The company, Willmark, was established in 1982 in Amritsar, India, and is recognized for its involvement in human and veterinary pharmaceuticals. A variety of dosage forms, such as tablets, capsules, injectables, and ophthalmic ointments, are produced for oral and topical uses. Services including contract manufacturing and ODM are offered, with approvals for Beta-Lactam and Non-Beta Lactam products in place. Strong customer relationships are maintained through reliable distribution channels, focusing on quality and mutual benefits in the healthcare sector.
Willmark offers Tablets and Capsules and Veterinary Products.
Willmark operates through Willmark Pharmaceuticals Private Limited.
The legal entities of Willmark currently have 2 directors, including Rajiv Bhardwaj, Rajan Bhardwaj.